Anders Hove

Managing Partner at Amzak Capital Management LLC

Anders Hove

Anders Hove

Managing Partner at Amzak Capital Management LLC

Overview
Career Highlights

Amzak Capital Management LLC
Bellevue Asset Management LLC
Bellevue Asset Management

RelSci Relationships

1239

Number of Boards

21

Birthday

1966

Age

54

Number of Awards

1

Relationships
RelSci Relationships are individuals Anders Hove likely has professional access to. A relationship does not necessarily indicate a personal connection.

Managing Partner, Life Sciences Team at Frazier Healthcare Partners

Relationship likelihood: Strong

Partner at Venrock Associates

Relationship likelihood: Strong

Former Director, President & Chief Executive Officer at PDS Biotechnology Corp.

Relationship likelihood: Strong

Managing Partner at Amzak Capital Management LLC

Relationship likelihood: Strong

Chief Financial Officer at Venrock Associates

Relationship likelihood: Strong

General Counsel at Venrock Associates

Relationship likelihood: Strong

Partner at Venrock Associates

Relationship likelihood: Strong

Partner at Venrock Associates

Relationship likelihood: Strong

Partner at Aisling Capital

Relationship likelihood: Strong

Former Chief Executive Officer & Director at PDL BioPharma, Inc.

Relationship likelihood: Strong

Paths to Anders Hove
Potential Connections via
Relationship Science
You
Anders Hove
Managing Partner at Amzak Capital Management LLC
Career History
Managing Partner
2017 - Current

Amzak Capital Management makes business development, debt and equity investments in a range of industries domestically and internationally. The firm target sectors include telecommunications sector in North America, the Caribbean and Latin America.They consider investments from a control perspective, as well as minority investments across the capital structure. The firm typically seeks to invest $3 million to $20 million per debt or minority interest transaction with an EBITDA of $5 to $25 million.

Professional
2003 - Current

VR Management LLC specializes in capital investment focuses on technology and health care sectors. The company is headquartered in Palo Alto, CA.

Managing Member
Prior - 2016

VHCP Management focuses on investments in the stocks of US and European small-cap companies in the health technology sector.

Boards & Committees
Director
Prior
Director
Prior
Political Donations
$2,500
2013
$2,500
2012
$2,500
2011
Investments
Details Hidden

The Medicines Co We are a global pharmaceutical company focused on advancing the treatment of critical care patients through the delivery of innovative, cost-effective medicines to the worldwide hospital marketplace. In the United States, we have three marketed products, Angiomax® (bivalirudin) for Injection, Cleviprex® (clevidipine) Injectable Emulsion, and Argatroban Injection, 50 mg per 50 mL†. We also have a pipeline of acute and intensive care hospital products in development, including three late-stage development product candidates, cangrelor, oritavancin and MDCO-157, and two early stage development product candidates, MDCO-2010 and MDCO-216. We believe that Angiomax, Cleviprex and our products in development possess favorable attributes that can satisfy unmet medical needs in the acute | intensive care hospital product market and offer, or, in the case of our products in development, have the potential to offer, improved performance to hospital businesses. The Company is publicly traded on the Nasdaq exchange under the ticker symbol MDCO. It was founded in 1996 and employs approximately 425 professionals.

Details Hidden

Monogram Biosciences, Inc. develops and commercializes diagnostic products for the treatment of human immunodeficiency virus (HIV) infection, hepatitis C virus (HCV) infection, and other viral illnesses, as well as cancer and other diseases. It offers HIV tests, including genotypic, phenotypic, tropism, and combined phenotype/genotype assays, as well as suppression management and viral load testing, HCV assays and oncology tests. The company was founded in 1995 and is headquartered in South San Francisco, CA.

Details Hidden

Third Wave Technologies, Inc. developed DNA and RNA detection technology. It provided molecular solutions for clinical, research, and agricultural customers. The company was founded in February 1993 and was headquartered in Madison, WI.

Awards & Honors
Rank #97
2011
Forbes Magazine - The Midas List
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Anders Hove. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Anders Hove's profile does not indicate a business or promotional relationship of any kind between RelSci and Anders Hove.